Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Organoplatinum compounds. 1987 update].

J M Extra1, M Espie, F Calvo

  • 1Clinique des Agents Anticancéreux, Hôpital Saint-Louis, Paris, France.

Nouvelle Revue Francaise D'Hematologie
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interplay between structural and magnetic ordering in model colloidal clusters of cubic particles.

Physical review. E·2026
Same author

Quantum dynamics of a two-dimensional model in a microcavity: Polaritonic states of the Hénon-Heiles system.

The Journal of chemical physics·2025
Same author

Conformational fluxionality of long-chain alkene clusters in the gas phase evidenced from a combined experimental and theoretical approach.

The Journal of chemical physics·2025
Same author

[Transition challenges to integrate adults' rehabilitation within the multimorbidity approach in Chile].

Rehabilitacion·2024
Same author

Radiative relaxation in isolated large carbon clusters: Vibrational emission versus recurrent fluorescence.

The Journal of chemical physics·2022
Same author

Functional activation of the periaqueductal gray matter during conditioned and unconditioned fear in guinea pigs confronted with the Boa constrictor constrictor snake.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2022
Same journal

XIVth Congress of the French Society of Hematology. Paris, France, February 3-4, 1995. Abstracts.

Nouvelle revue francaise d'hematologie·1995
Same journal

Improved detection of CD2 on formaldehyde-fixed non dehydrated cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Engraftment of CD34+ peripheral blood progenitor cells into multiple myeloma patients following total body irradiation.

Nouvelle revue francaise d'hematologie·1995
Same journal

Allogeneic transplantation of peripheral blood progenitor cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Selection and expansion of CD34+ cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Ex vivo hematopoietic cell expansion: a theoretical and technological challenge.

Nouvelle revue francaise d'hematologie·1995
See all related articles

Cisplatin is a potent chemotherapy drug but causes severe side effects. Carboplatin offers similar efficacy with better tolerance, mainly causing blood-related toxicities. Newer platinum derivatives show promise for cancer treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Medicinal Chemistry

Context:

  • Cisplatin is a widely used platinum-based chemotherapy agent effective against various cancers.
  • Significant gastrointestinal, renal, and neurological toxicities limit cisplatin's utility, especially at high doses.
  • Carboplatin and iproplatin are platinum analogs with differing toxicity profiles.

Purpose:

  • To review the efficacy and toxicity of cisplatin and its platinum-based analogs.
  • To compare the therapeutic outcomes and side effect profiles of cisplatin, carboplatin, iproplatin, and newer platinum derivatives.
  • To evaluate the potential of novel platinum compounds in cancer therapy.

Summary:

  • Cisplatin is highly effective in testicular, ovarian, and head and neck cancers but is limited by severe toxicities.

Related Experiment Videos

  • Carboplatin demonstrates comparable efficacy to cisplatin in several cancers with improved tolerance, primarily causing hematological toxicity.
  • Iproplatin offers no clear advantage over carboplatin, while novel diaminocyclohexane-platinum derivatives show promise in early studies.

    • Impact:

    • Highlights the trade-offs between efficacy and toxicity in platinum-based chemotherapy.
    • Identifies carboplatin as a more tolerable alternative to cisplatin for specific cancer types.
    • Suggests that emerging platinum derivatives may offer improved therapeutic options with reduced side effects.